PFSA
Profusa, Inc.
$0.2950
+10.07%
$1.3M
No data for this timeframe.
Vol
Market Cap$1.3M
Cap SizeNano Cap
Insider Activity2B / 0S
Insider Net $$7.0T
Reddit Sentiment73° Bullish
SEC Reports3
Press Releases1
Exchange OTC·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001859807·Prev Close $0.2680
Recent Activity
May 15, 2026
Press
Profusa announced it will be listed on the Nasdaq Capital Market effective May 15, 2026, as the first milestone in a com
Impact 4/10
May 15, 2026
announcement
Profusa Announces Listing Transfer to The Nasdaq Capital Market
<p align="justify">BERKELEY, CA, May 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the
May 6, 2026
SEC
Two insiders (a Director and the CFO) each purchased 1.87 million shares at ~$1.87M per share, for a combined total of ~
CLUSTER — Impact 6/10
May 4, 2026
Insider
STOVER JACK E bought 1,869,796 shares
Director @ $1,869,796.00 ($3.5T)
May 4, 2026
Insider
Knechtel Fred S. bought 1,869,796 shares
Chief Financial Officer @ $1,869,796.00 ($3.5T)
Mar 13, 2026
SEC
Analysis based on filing metadata only — document content was unavailable. The 8-K reports three significant events: ter
8-K — Impact 8/10
Mar 4, 2026
SEC
Profusa, Inc. has announced the effectiveness of its SEC registration statement (File No. 333-293451), allowing the comp
EFFECT — Impact 4/10
Jan 26, 2026
Insider
O'Rourke Peter sold 15,250 shares
Director @ $0.00 ($0.00)
Latest Reports
NEUTRAL
Press
4/10
Profusa announced it will be listed on the Nasdaq Capital Market effective May 15, 2026, as the first milestone in a com
May 15, 2026
MIXED
CLUSTER
6/10
Two insiders (a Director and the CFO) each purchased 1.87 million shares at ~$1.87M per share, for a combined total of ~
May 6, 2026
BEARISH
8-K
8/10
Analysis based on filing metadata only — document content was unavailable. The 8-K reports three significant events: ter
Mar 13, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 4, 2026 | STOVER JACK | BUY | $3.5T |
| May 4, 2026 | Knechtel Fred | BUY | $3.5T |
| Jan 26, 2026 | O'Rourke Peter | J | $0.00 |
| Jan 26, 2026 | O'Rourke Peter | J | $0.00 |
| Jan 26, 2026 | STOVER JACK | J | $0.00 |
Reddit Sentiment
73°
Bullish
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
5 unique insiders with 2 transactions. Net insider value: $7.0T ($7.0T bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 4, 2026 | STOVER JACK E | Director | BUY | 1,869,796 | $1,869,796.00 | $3.5T |
| May 4, 2026 | Knechtel Fred S. | Chief Financial Officer | BUY | 1,869,796 | $1,869,796.00 | $3.5T |
| Jan 26, 2026 | O'Rourke Peter | Director | J | 15,250 | $0.00 | $0.00 |
| Jan 26, 2026 | O'Rourke Peter | Director | J | 107,750 | $0.00 | $0.00 |
| Jan 26, 2026 | STOVER JACK E | Director | J | 380,280 | $0.00 | $0.00 |
| Jan 26, 2026 | STOVER JACK E | Director | J | 553,665 | $0.00 | $0.00 |
| Jan 26, 2026 | Chung Lauren | Director | J | 30,000 | $0.00 | $0.00 |
| Jan 26, 2026 | NorthView Sponsor I, LLC | 10%+ Owner | J | 4,743,750 | $0.00 | $0.00 |
| Jan 26, 2026 | NorthView Sponsor I, LLC | 10%+ Owner | J | 5,162,500 | $0.00 | $0.00 |
| Jan 26, 2026 | Knechtel Fred S. | Chief Financial Officer | J | 818,961 | $0.00 | $0.00 |
| Jan 26, 2026 | Knechtel Fred S. | Chief Financial Officer | J | 516,863 | $0.00 | $0.00 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 1 neutral. Avg impact: 6.0/10.
MIXED
CLUSTER
6/10
Two insiders (a Director and the CFO) each purchased 1.87 million shares at ~$1.87M per share, for a
May 6, 2026
BEARISH
8-K
8/10
Analysis based on filing metadata only — document content was unavailable. The 8-K reports three sig
Mar 13, 2026
NEUTRAL
EFFECT
4/10
Profusa, Inc. has announced the effectiveness of its SEC registration statement (File No. 333-293451
Mar 4, 2026
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
73°
Bullish
Bearish
Neutral
Bullish
7 mentions
5 bullish
0 bearish
5 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 6, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 6, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Apr 6, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| Apr 6, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| Feb 22, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
criterias to find the ONE
▲ 1
💬 1
⚡ 0.5
May 15, 2026
announcement
Profusa Announces Listing Transfer to The Nasdaq Capital Market
<p align="justify">BERKELEY, CA, May 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a digital health comp
May 8, 2026
other
Profusa Receives Favorable Nasdaq Listing Determination
<p align="justify">BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a digital health comp
May 5, 2026
other
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value
<p>Company focusing resources on near-term commercial milestones; European CE Mark process and Healthcare Research revenue opportunities</p>
Apr 28, 2026
short_volume
Short Volume: PFSA — 58.3% short (1.1M / 1.9M)
Short: 1,079,251 | Exempt: 128,982 | TRF Vol: 1,851,328 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)
Apr 7, 2026
short_interest
FTD: PFSA — 837,938 shares ($1.6M) failed to deliver
Settlement: 20260407, Price: $1.85, FTD Value: $1,550,185.3, PROFUSA INC COM NEW
Apr 6, 2026
other
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
<p align="center"><i>Company secures scalable multi-omics diagnostics platform and launches Mayo Clinic partnership adding to Lumee real-time biochemi
Apr 6, 2026
earnings_calendar
PFSA Q4 2025 Earnings Scheduled — 2026-04-06
Apr 6, 2026
short_volume
Short Volume: PFSA — 56.8% short (39.3M / 69.1M)
Short: 39,265,623 | Exempt: 349,655 | TRF Vol: 69,071,907 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
short_volume
Short Volume: PFSA — 56.0% short (0.9M / 1.6M)
Short: 874,417 | Exempt: 3,230 | TRF Vol: 1,561,465 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
earnings_calendar
PFSA Q4 2025 Earnings Scheduled — 2026-03-23